Israel’s Mitrassist Medical (reported here previously) has advanced to human trials of its innovative heart valve implant that avoids the risks of stopping the heart during open heart surgery. Mitrassist has just raised funds to recruit more employees and tackle additional structural heart diseases.
https://www.calcalistech.com/ctech/articles/0,7340,L-3878551,00.html